A method for the prevention of hypoglycaemia in diabetes mellitus type 2 comprising administering(a) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and(b) metformin or/and a pharmaceutically acceptable salt thereof, to a subject in need thereof.